chartexchange

ARGX
argenx SE
stockNASDAQADR

At CloseNov 13, 2026 3:59:55 PM EST
959.78USD-2.196%(-21.55)225,894
After-hoursNov 13, 2026 4:00:30 PM EST
960.04USD+0.027%(+0.26)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Tim Van Hauwermeiren
HQ
Amsterdam, Noord Brabant, Netherlands
Previous Close
$981.33
Beta
0.53
52-Week High
$1,072.75 2026-09-02
52-Week Low
$661.85 2026-03-20
SMA 50
$925.75
SMA 200
$859.72
Avg. Vol 10D
419,329
Avg. Vol 30D
473,603
Avg. Vol 90D
344,436
Relative Vol
0.48
59.28M
0.4100%
555
ARGX Profile

Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.

ARGX Performance
PeriodPriceDateChangeBeta
1W927.212026-11-06+3.46%0.928
1M802.642026-10-13+19.51%1.207
3M856.942026-08-13+11.94%0.964
6M802.702026-05-13+19.50%0.382
1Y891.732025-11-13+7.57%0.530
2Y599.352024-11-13+60.05%—
5Y309.642021-11-12+209.80%0.609
ARGX Stock Summary

argenx SE (NASDAQ:ARGX) stock price today is $959.27, and today's volume is 225,894. ARGX is down 2.248% today. The 30 day average volume is 473,603. ARGX market cap is $60.32B with 62.89M shares outstanding.